Navigation Links
Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
Date:6/4/2008

SF1126 is a small-molecule conjugate containing a pan-PI3K inhibitor that selectively inhibits all PI3K class I isoforms. In addition to inhibiting PI3 kinase, SF1126 inhibits mTOR, DNA-PK, Polo-like 1 kinases, PIM1 and CK2 - all believed to play significant roles in the control of cell survival/proliferation signals and in cancer. SF1126 is the only PI3K inhibitor demonstrated in preclinical studies to cause an oxidative stress mechanism in cancer cells, resulting in decreased proliferation and apoptosis. A major factor in tumor resistance to approved chemotherapy agents is thought to be the activation of the PI3K/PTEN pathway. As a result, it is believed that inhibiting this pathway with SF1126 could resensitize the cancer cells to approved anticancer agents and lead to possible synergistic anticancer activity. Clinical combination studies with SF1126 are being planned.

About Semafore Pharmaceuticals

Semafore Pharmaceuticals is a clinical-stage drug discovery and development company focused on small-molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus - cancer. Semafore is one of the first biopharmaceutical companies to focus on both PI3K and PTEN and has successfully discovered and is developing a portfolio of drug candidates addressing these targets.

Semafore is actively seeking partnerships or other strategic alliances to help fulfill the promise of SF1126. For more information visit the company's Web site at http://www.SemaforePharma.com .

Contacts:

Semafore Pharmaceuticals Inc.

Sandi Yurichuk

(650) 576-5769

sandi.yurichuk@semaforepharma.com

Russo Partners LLC

David Schull

(212) 845-4271

david.schull@russopartn
'/>"/>

SOURCE Semafore Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
2. Semafores SF1126 Exhibits Antitumor and Antiangiogenic Activity
3. Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der ... Die interaktive PDF, verfügbar unter pharmaserialisation.com , ... dem sie jeweils in Kraft treten. ... Serialisierung nicht länger um das "ob", sondern darum, ...
(Date:9/19/2014)... -- CytRx Corporation (Nasdaq: CYTR ), a biopharmaceutical ... that David J. Haen , Vice President, Business ... Biotech Industry Conference on Friday, September 26 th at ... at the Millennium Broadway Hotel in New ... archived webcast of the presentation will be available on ...
(Date:9/19/2014)... Sept. 19, 2014  PCI is pleased to ... Biotec is a leading provider of Clinical Trial ... Bridgend, Wales in the ... significantly expands PCI,s presence in the UK/EU to ... adding packaging, storage and distribution capacity, as well ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
(Date:9/21/2014)... (PRWEB) September 21, 2014 Top10BestSEOHosting.com, ... ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the most ... want to buy high quality hosting products. ... good hosting suppliers; we recommend two great hosting ... says, “We believe that iPage and GreenGeeks are ...
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s dresses and ... announced evening cocktail dresses . As a matter ... are very popular among worldwide customers. Now, all its ... to 65 percent off). , All UWDress.com’s employees ... outfits for the global clients. The company is famous ...
(Date:9/20/2014)... Vegas, NV (PRWEB) September 21, 2014 ... improvement method developed by fitness expert Michael Wren that ... lose stubborn weight and reverse health conditions like high ... the attention of Shane Michaels, prompting an investigative review. ... loss methods and tips upside down by showing people ...
(Date:9/20/2014)... 2014 David Cooke presented two scientific ... poster looked at the clinical benefits of MPI gated ... diastolic function. In conjunction with colleagues at Emory University, ... normal LVEF by echo (>50%). Each patient had same-day ... SPECT. Emory Toolbox 4.0 was used to ...
(Date:9/20/2014)... Islands of Loreto, Baja, Mexico (PRWEB) September 20, 2014 ... of Loreto today announced the resort did not experience ... fully operational, with all amenities and activities available. , ... September 14, 2014, bringing intense wind, rain and powerful ... Baja Peninsula, Villa del Palmar Islands of Loreto experienced ...
Breaking Medicine News(10 mins):Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3
... The Board of,Directors of Golden Meditech Company ... to announce today that the Company has ... market through the,acquisition of Topshine Hospital Management ... largest private haematologist hospitals with,presence in Beijing ...
... at-home blood pressure checks can help control hypertension without ... study of more than 700 Group Health patients ... American Medical Association . , "To our knowledge, ... use Web-based care and a patient-shared electronic medical record ...
... FRANCISCO, June 24 Stewart M. Kiner has,been ... senior market for Blue,Shield of California. In this ... business planning and overall leadership for,the senior market ... and Medicare Part D Drug Plans. Kiner will ...
... Avoid Medicare Cuts and Caps Moves Forward, ... Association (APTA) today hailed passage of the Medicare,Improvements ... the US House of,Representatives as a significant step ... the US Senate to quickly follow suit., ...
... June 24 Neighbors and friends are gathering,June 28th ... isn,t full of rock,stars. It,s Kathie McClure, her family ... the country,gathering stories and talking to people about America,s ... and attorney who learned about the holes in,our health ...
... to imatinib (Gleevec) in patients with chronic myelogenous leukemia ... of the Journal of the National Cancer Institute ... diagnosed CML patients. However, some patients develop resistance to ... in response to mutations in the BCR-ABL gene. In ...
Cached Medicine News:Health News:Golden Meditech Pioneers into China's Hospital Market 2Health News:Golden Meditech Pioneers into China's Hospital Market 3Health News:Golden Meditech Pioneers into China's Hospital Market 4Health News:New online care for hypertension gets results 2Health News:Blue Shield of California Appoints Industry Veteran as New Vice President and General Manager for Senior Market 2Health News:Physical Therapists Applaud House Passage of Medicare Package 2Health News:Mom and Purple Bus Kick-off VoteHealthcare.org Bandwagon Tour 2Health News:Activation of LYN kinase is associated with imatinib-resistance in CML patients 2
... The Lo-Profile™ tracheostomy tube is cosmetically ... ,Two styles of inner cannula come ... inner cannula and a 15 mm ... hook-up. The semi-reusable inner cannula may ...
Disposable Cannula Cuffless Tracheostomy Tubes...
Tube, tracheostomy, cuffed, size 8.0, SS, spiral reinforced PVC....
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
Medicine Products: